Panagora Asset Management Inc Organon & Co. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $1,117 - $1,428	-58 Reduced 0.58%	9,972 $207,000
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $873,550 - $1.31 Million	-40,782 Reduced 80.26%	10,030 $235,000
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $579,393 - $711,130	-24,856 Reduced 32.85%	50,812 $1.42 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $870,854 - $1.27 Million	37,216 Added 96.79%	75,668 $1.77 Million
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $36,187 - $44,462	-1,143 Reduced 2.89%	38,452 $1.3 Million
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $589,268 - $761,694	19,352 Added 95.6%	39,595 $1.38 Million
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $117,633 - $152,344	4,103 Added 25.42%	20,243 $616,000
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $415,993 - $517,849	-14,530 Reduced 47.38%	16,140 $529,000
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $872,561 - $1.17 Million	30,670 New	30,670 $928,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.